ZNF630: A Potential Drug Target and Biomarker for Various Diseases
ZNF630: A Potential Drug Target and Biomarker for Various Diseases
ZNF630 (MGC138344) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZNF630 is a non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is a key regulator of cell proliferation and has been involved in the development and progression of many diseases.
The ZNF630 gene was first identified in the late 1990s using transcriptomic studies. It is located on chromosome 6 and has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis (programmed cell death). ZNF630 has also been shown to be involved in the regulation of gene expression and has been identified as a potential drug target in various diseases.
One of the most promising aspects of ZNF630 is its potential as a drug target for cancer. Cancer is a leading cause of death worldwide and is a major driver of disability. Many cancer treatments are effective in the short term but have a negative impact on quality of life and survival in the long term. Therefore, identifying potential drug targets is a promising way to improve cancer treatment outcomes. ZNF630 has been shown to be involved in the regulation of cell proliferation and has been identified as a potential drug target for various cancers, including breast, ovarian, and colorectal cancers.
ZNF630 has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. These conditions are characterized by the progressive loss of brain cells and can have a significant impact on an individual's quality of life and independence. ZNF630 has been shown to be involved in the regulation of neurodegenerative disease-related gene expression and has been identified as a potential drug target for these conditions.
In addition to its potential as a drug target, ZNF630 has also been shown to be involved in the regulation of autoimmune disorders. Autoimmune disorders are a leading cause of disease and can cause significant morbidity and mortality. ZNF630 has been shown to be involved in the regulation of autoimmune disorder-related gene expression and has been identified as a potential drug target for these conditions.
Overall, ZNF630 is a promising gene that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its functions and potential clinical applications.
Protein Name: Zinc Finger Protein 630
Functions: May be involved in transcriptional regulation
More Common Targets
ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761